| Uremia alters HDL composition and function M Holzer, R Birner-Gruenberger, T Stojakovic, D El-Gamal, V Binder, ... Journal of the American Society of Nephrology 22 (9), 1631-1641, 2011 | 302 | 2011 |
| Psoriasis alters HDL composition and cholesterol efflux capacity [S] M Holzer, P Wolf, S Curcic, R Birner-Gruenberger, W Weger, M Inzinger, ... Journal of lipid research 53 (8), 1618-1624, 2012 | 178 | 2012 |
| Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies ZA Hing, HYJ Fung, P Ranganathan, S Mitchell, D El-Gamal, JA Woyach, ... Leukemia 30 (12), 2364-2372, 2016 | 135 | 2016 |
| BRD4 profiling identifies critical chronic lymphocytic leukemia oncogenic circuits and reveals sensitivity to PLX51107, a novel structurally distinct BET inhibitor HG Ozer, D El-Gamal, B Powell, ZA Hing, JS Blachly, B Harrington, ... Cancer discovery 8 (4), 458-477, 2018 | 117 | 2018 |
| Myeloperoxidase-derived chlorinating species induce protein carbamylation through decomposition of thiocyanate and urea: novel pathways generating dysfunctional high-density … M Holzer, K Zangger, D El-Gamal, V Binder, S Curcic, V Konya, ... Antioxidants & redox signaling 17 (8), 1043-1052, 2012 | 103 | 2012 |
| Selinexor suppresses downstream effectors of B-cell activation, proliferation and migration in chronic lymphocytic leukemia cells Y Zhong, D El-Gamal, JA Dubovsky, KA Beckwith, BK Harrington, ... Leukemia 28 (5), 1158-1163, 2014 | 72 | 2014 |
| The urea decomposition product cyanate promotes endothelial dysfunction D El-Gamal, SP Rao, M Holzer, S Hallström, J Haybaeck, M Gauster, ... Kidney international 86 (5), 923-931, 2014 | 63 | 2014 |
| PKC-β as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL D El-Gamal, K Williams, TD LaFollette, M Cannon, JS Blachly, Y Zhong, ... Blood, The Journal of the American Society of Hematology 124 (9), 1481-1491, 2014 | 56 | 2014 |
| Targeting BTK through microRNA in chronic lymphocytic leukemia A Bottoni, L Rizzotto, TH Lai, C Liu, LL Smith, R Mantel, S Reiff, ... Blood, The Journal of the American Society of Hematology 128 (26), 3101-3112, 2016 | 45 | 2016 |
| Cyanate is a novel inducer of endothelial icam-1 expression D El-Gamal, M Holzer, M Gauster, R Schicho, V Binder, V Konya, ... Antioxidants & redox signaling 16 (2), 129-137, 2012 | 39 | 2012 |
| The myeloperoxidase product hypochlorous acid generates irreversible high-density lipoprotein receptor inhibitors V Binder, S Ljubojevic, J Haybaeck, M Holzer, D El-Gamal, R Schicho, ... Arteriosclerosis, thrombosis, and vascular biology 33 (5), 1020-1027, 2013 | 32 | 2013 |
| Bromodomain and extraterminal protein inhibitor, apabetalone (RVX-208), reduces ACE2 expression and attenuates SARS-Cov-2 infection in vitro D Gilham, AL Smith, L Fu, DY Moore, A Muralidharan, SPM Reid, ... Biomedicines 9 (4), 437, 2021 | 26 | 2021 |
| Binding of the SARS-CoV-2 envelope E protein to human BRD4 is essential for infection KR Vann, A Acharya, SM Jang, C Lachance, M Zandian, TA Holt, ... Structure 30 (9), 1224-1232. e5, 2022 | 22 | 2022 |
| BRD4 profiling identifies critical chronic lymphocytic leukemia oncogenic circuits and reveals sensitivity to PLX51107, a novel structurally distinct BET inhibitor. Cancer … HG Ozer, D El-Gamal, B Powell, ZA Hing, JS Blachly, B Harrington, ... DOI: https://doi. org/10.1158/2159-8290. CD-17-0902. PMID: https://www. ncbi …, 0 | 14 | |
| Perturbation of the gut microbiome and association with outcomes following autologous stem cell transplantation in patients with multiple myeloma C D’Angelo, S Sudakaran, F Asimakopoulos, P Hematti, D El-Gamal, ... Leukemia & lymphoma 64 (1), 87-97, 2023 | 9 | 2023 |
| The Eµ-Myc/TCL1 Transgenic Mouse As a New Aggressive B-Cell Malignancy Model Suitable for Preclinical Therapeutics Testing KA Rogers, D El-Gamal, HK Bonnie, HA Zachary, GM Virginia, M Rose, ... Blood 126 (23), 2752, 2015 | 8 | 2015 |
| Combinatorial inhibition of BTK, PI3K-AKT and BRD4-MYC as a strategy for treatment of mantle cell lymphoma KR Vann, D Pal, AL Smith, N Sahar, M Krishnaiah, D El-Gamal, ... Molecular Biomedicine 3, 1-11, 2022 | 7 | 2022 |
| Defining the role of the gut microbiome in the pathogenesis and treatment of lymphoid malignancies S Upadhyay Banskota, SA Skupa, D El-Gamal, CR D’Angelo International journal of molecular sciences 24 (3), 2309, 2023 | 6 | 2023 |
| A novel triple-action inhibitor targeting B-cell receptor signaling and BRD4 demonstrates preclinical activity in chronic lymphocytic leukemia AL Smith, AP Eiken, SA Skupa, DY Moore, LT Umeta, LM Smith, ... International journal of molecular sciences 23 (12), 6712, 2022 | 6 | 2022 |
| Insect cell expression and purification of recombinant SARS‐COV‐2 spike proteins that demonstrate ACE2 binding LR Struble, AL Smith, WE Lutz, G Grubbs, S Sagar, KW Bayles, ... Protein Science 31 (5), e4300, 2022 | 6 | 2022 |
